Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriflunomide in first clinical episode suggestive of multiple sclerosis
2006-001152-12Phase 3Completed
- Sponsor
- Sanofi
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of teriflunomide in multiple sclerosis (MS) (3 arms), sponsored by Sanofi. Primary endpoint: Conversion to clinically definite multiple sclerosis. Started Aug 2007; status: completed.
02
Drugs
teriflunomide
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2006-001152-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001152-12.